West Pharmaceutical Services Inc
F:WPS
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
W
|
West Pharmaceutical Services Inc
F:WPS
|
US |
Intrinsic Value
The intrinsic value of 
West Pharmaceutical Services Inc (WPS) under the Base Case is 280.5 EUR per share.
Compared with the current market price of 350 EUR, the stock appears
Overvalued by 20% .
The intrinsic value is calculated using valuation multiples.
Do our valuations actually work? See backtest results .
Cheap or expensive for this stock?
This block shows whether today’s valuation is cheap or expensive compared with the stock’s own history, and what happened after similar valuations in the past.
We compare the gap between the stock’s price and our estimated value over time.
- Undervalued can still be historically expensive. The stock may trade below our estimated value, but usually offer an even bigger discount.
- Overvalued can still be historically cheap. The stock may trade above our estimated value, but usually carry an even higher premium.
Market expectations can differ from our model, which may not fully capture everything affecting the price. That is why some stocks regularly trade above our estimated value and others below it.
The scale and chart show how today’s valuation compares with the past. The cards summarize past returns and waiting times until the stock stopped being cheap or expensive. This can happen because the price changed, our estimated value changed, or both.
Only completed periods are included. These are past results, not forecasts. The usual historical range does not necessarily mean fair value.
Fundamental Analysis
What West Pharmaceutical Services Does
West Pharmaceutical Services makes the small but essential parts used to store, seal, and deliver injectable medicines. Its products include rubber stoppers, seals, syringe and vial components, and drug containment and delivery systems that help protect medicines from contamination and keep them usable from factory to patient.
- Headquarters
- United States of America US
- Employees
- 10 800
- IPO date
- Jul 27, 1923
West Pharmaceutical Services has a wide economic moat
Replacing West’s components in an approved injectable medicine can require costly testing and regulatory updates, giving drugmakers a strong reason to stay. Patents and exclusive technology licenses also prevent rivals from freely copying parts of its drug packaging and delivery range.
Read the full moat analysis
Revenue & Expenses Breakdown
West Pharmaceutical Services Inc
Earnings Waterfall
West Pharmaceutical Services Inc
The intrinsic value for West Pharmaceutical Services Inc (WPS) under the Base Case is 280.5 EUR.
Compared with the current market price of 350 EUR, the stock appears Overvalued by 20% .